Neuronetics Inc.

Last updated September 27, 2026

Organization details

Legal name
Neuronetics Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
3841 — Surgical & Medical Instruments & Apparatus
Jurisdiction of incorporation
Delaware
Headquarters city
Malvern
Headquarters state / province
Pennsylvania
Headquarters country
United States
Fiscal year end
December
Ticker symbol
STIM
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001227636
Wikidata ID
Q7002474

Board of directors

Chief executives

Keith J. Sullivan · President and CEO
Dates unknown

Director election results

Annual meeting of May 28, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

5 of this board's directors also sit on 9 other boards. 6 are in the same sector.

Network of Neuronetics Inc.'s board connections Anika Therapeutics Inc. Anika Therapeutics Inc... Celestica Inc. Celestica Inc. Cytek Biosciences Inc. Cytek Biosciences Inc. KORU Medical Systems Inc. KORU Medical Systems I... Mirion Technologies Inc. Mirion Technologies In... Repligen Corporation Repligen Corporation TELA Bio Inc. TELA Bio Inc. Treace Medical Concepts Inc. Treace Medical Concept... Xtant Medical Holdings Inc. Xtant Medical Holdings... Glenn P. Muir Glenn P. Muir John K. Bakewell John K. Bakewell Joseph H. Capper Joseph H. Capper Robert Cascella Robert Cascella Sheryl L. Conley Sheryl L. Conley Neuronetics Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$4,851,108
15 purchases by 1 insider
Sold, last 12 months
$270,404
10 sales by 3 insiders
Date Insider Transaction Shares Price Value
Oct 30, 2026 Chernett Jorey 10% owner Open-market purchase +18,000 $2.27 $40,860
Aug 14, 2026 Chernett Jorey 10% owner Open-market purchase +14,000 $3.16 $44,240
Jul 23, 2026 Naor Nir Officer (EVP, CFO & Treasurer) Grant or award +500,000 — —
Jul 14, 2026 Chernett Jorey 10% owner Open-market purchase +35,000 $1.78 $62,300
Jun 15, 2026 Avinash Amin Director Other −2,934 — —
Jun 15, 2026 Avinash Amin Director Other −34,932 — —
Jun 15, 2026 Avinash Amin Director Other −4,634 — —
Jun 15, 2026 Madryn Health Partners II, LP 10% owner Other +2,934 — —
Jun 15, 2026 Madryn Health Partners II, LP 10% owner Other +34,932 — —
Jun 15, 2026 Madryn Health Partners II, LP 10% owner Other +4,634 — —
May 28, 2026 Madryn Health Partners II, LP 10% owner Other +2,071 — —
May 28, 2026 Megan Rosengarten Director Grant or award +30,000 — —
May 28, 2026 Glenn P. Muir Director Grant or award +30,000 — —
May 28, 2026 Sasha Cucuz Director Grant or award +30,000 — —
May 28, 2026 Sheryl L. Conley Director Grant or award +30,000 — —

Organizations in the same sector, closest in location and size first.

Questions about Neuronetics Inc.

Who is the CEO of Neuronetics Inc.?

Keith J. Sullivan is Neuronetics Inc.'s President and CEO.

How many directors are on Neuronetics Inc.'s board?

Neuronetics Inc.'s board has 10 directors: Avinash Amin, Glenn P. Muir, John K. Bakewell, Joseph H. Capper, Keith J. Sullivan, Megan Rosengarten, Robert Cascella, Sasha Cucuz, Sheryl L. Conley and Wilfred E. Jaeger.

Are Neuronetics Inc. insiders buying or selling shares?

Over the last 12 months, Neuronetics Inc. insiders bought $4.9 million of shares in 15 purchases and sold $270,404 of shares in 10 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="neuronetics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.